Friday 6 November 2026 Export RGEN’s income statement to Excel — free account

Repligen Corporation

RGEN Healthcare Medical Instruments & Supplies

Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024.

Revenue: +10.9%
EPS: −351.9%
Free cash flow: −11.5%
Total debt: +3.28%

Quarter to September 2026, against a year earlier

169.01 9.19 −5.16%

Follow RGEN

Alert me

Market cap: $10.8B
P/E: 0.0×
Fwd P/E: −615×
Dividend yield: —
F-score: 6/9
Altman Z: 7.49
Beneish M: −2.52
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Repligen Corporation (RGEN) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Repligen Corporation (RGEN) trades at a P/S ratio of 11.9×. Over the past ten years it has ranged from 7.6× (May 2026) to 35.0× (September 2021); the current reading is higher than 32% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/RGEN/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Repligen Corporation P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/RGEN/metrics/ps-ratio">Repligen Corporation (RGEN) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	12.5×	(1.65%)
FY2024	12.7×	(19.67%)
FY2023	15.8×	40.94%
FY2022	11.2×	(48.41%)
FY2021	21.7×	(20.97%)
FY2020	27.5×	66.17%
FY2019	16.5×	39.09%
FY2018	11.9×	18.58%
FY2017	10.0×	0.29%
FY2016	10.0×	(10.16%)

Period	P/S ratio	Change
Sep 2026	13.5×	37.64%
Jun 2026	9.8×	12.72%
Mar 2026	8.7×	(30.31%)
Dec 2025	12.5×	17.48%
43 more quarters	Free account

Against its own ten years

Low 7.6× High 35.0×

Ten-year median 12.9×

Current reading's percentile 33

Company	P/S ratio
BAX Baxter International Inc. compare	1.1×
BLCO Bausch + Lomb Corporation compare	1.3×
AVTR Avantor, Inc. compare	1.5×
SOLV Solventum Corporation compare	1.8×
ATR AptarGroup, Inc. compare	2.3×
ALGN Align Technology, Inc. compare	2.7×
COO The Cooper Companies, Inc. compare	2.9×
TFX Teleflex Incorporated compare	2.9×
RGEN Repligen Corporation	11.9×
Medical Instruments & Supplies industry median	2.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Repligen Corporation (RGEN) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on RGEN

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on RGEN

Stockrow Weekly